Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Spinal Disorders
Spinal Disorders News
EULARReal-World Tradeoffs of Biosimilars in Spotlight at EULARHead-to-head drug comparisons and clinical trials designed to answer the toughest questions in rheumatology will be featured at the upcoming European League Against Rheumatism (EULAR) Congress.
Medscape Medical News, June 12, 2017
'Fears Allayed' by Latest Infliximab Biosimilar EvidenceThe biosimilar is noninferior to the originator infliximab in patients with stable Crohn's disease, ulcerative colitis, and other inflammatory conditions, two studies demonstrate.